The main concern regarding women with positive anti-Ro/SSA antibodies is the risk of giving birth to children with neonatal lupus, which leads not only to cutaneous or hematological manifestations (anemia, thrombocytopenia), but also to consequences such as CHB. Here, TRIM21 is linked to anemia.